Equibles does not estimate personal net worth.
Get an email with a short summary when Lemaitre Vascular Inc publishes a filing, an earnings call transcript or a press release.
Get LMAT alertsDorian LeBlanc is recorded as CFO at Lemaitre Vascular Inc (LMAT). The newest filing on record that lists Dorian LeBlanc as CFO at Lemaitre Vascular Inc (LMAT) is dated April 14, 2026. Lemaitre Vascular Inc reported in an 8-K filed February 13, 2025 that Dorian LeBlanc was appointed Chief Financial Officer and principal financial officer, effective March 10, 2025. Dorian LeBlanc has spoken on 6 earnings calls and 8 other investor events across 1 company, most recently for Lemaitre Vascular Inc on September 22, 2026. Lemaitre Vascular Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Lemaitre Vascular Inc includes George LeMaitre (CEO), David Hissong (General Counsel), John A. Roush (Board Member) and 6 others.
“On February 7, 2025, LeMaitre Vascular, Inc. (the “Company”) agreed to terms with Dorian LeBlanc to become the Chief Financial Officer and principal financial officer of the Company, effective on March 10, 2025.”
“With me on today's call is our CEO, George LeMate, and our President, Dave Roberts. Before we begin, I'll read our safe harbor statement.”
“With me on today's call is our CEO, George LeMate, and our President, Dave Roberts. Before we begin, I'll read our safe harbor statement.”
“With me on today's call is our CEO, George LeMate, and our President, Dave Roberts. Before we begin, I'll read our Safe Harbor Statement.”
“With me on today's call is our CEO, George Lemaitre, and our president, Dave Roberts. Before we begin, I'll read our safe harbor statement.”
“With me on today's call is our CEO, George Lemaitre, and our president, Dave Roberts. Before we begin, I'll read our safe harbor statement.”
Start not stated–present
Last confirmed April 14, 2026
Medical Instruments & Supplies · Healthcare
CFO
